Brian Birchler, EVP, Corporate and Development Operations at IONIS PHARMACEUTICALS INC (IONS), sold 8,000 shares at $76.17 ($609K) on 2025-11-06, disclosed to the SEC on 2025-11-07.
Scheduled sale ($609k) by EVP, Corporate and Development Operations under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| IONS | SELL | 2026-01-20 | $637K | — | Filing → |
| IONS | SELL | 2025-10-16 | $3.4M | — | Filing → |
| IONS | SELL | 2025-04-17 | $19K | — | Filing → |